Neuren Pharmaceuticals - Latest News [Page 1]
US Defense Approves Funding for NNZ-2566 Trials
Monday, 21 January 2008, 3:27 pm | Neuren Pharmaceuticals
Neuren Pharmaceuticals (ASX:NEU) today announced that the US Department of Defense (DOD) has approved a proposal by the US Army Walter Reed Army Institute of Research (WRAIR) to provide US$4 million in funding for the Company’s second lead compound ... More >>
Neuren: A$10.1m Non-renounceable Rights Issue
Wednesday, 19 December 2007, 2:10 pm | Neuren Pharmaceuticals
Neuren Pharmaceuticals Limited (ASX: NEU) advises that it will undertake a non-renounceable rights issue to raise up to A$10.1 million. More >>